Acute Myelocytic Leukemia

Search Trials
A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
Status:
Active, not recruiting
Last Changed:
Oct 18, 2021
First Changed:
Jul 2, 2015
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
BemcentinibCytarabineDecitabine
PRGN-3006 Adoptive Cellular Therapy for Relapsed or Refractory AML or High Risk MDS
Status:
Recruiting
Last Changed:
Oct 19, 2021
First Changed:
Apr 25, 2019
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
PRGN-3006 T Cells
Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS
Status:
Recruiting
Last Changed:
Oct 21, 2021
First Changed:
Nov 18, 2019
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Haplo SCT with NK cellsHaplo SCT
A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Status:
Not yet recruiting
Last Changed:
Dec 1, 2021
First Changed:
Dec 1, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
IMM01Azacitidine
Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction Therapies
Status:
Not yet recruiting
Last Changed:
Nov 17, 2021
First Changed:
Nov 17, 2021
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
collection of biological samples and clinical data

Connect. Empower. Inspire.